Sarkoidoz Kardiyak Pacing ve ICD

Naruse Y, Sekiguchi Y, Nogami A, et al. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis. Circulation: Arrhythmia and Electrophysiology, 2014;7(3): 407-413.

Thomas P D, Hunninghake G.W. Current concepts of the pathogenesis of sarcoidosis. American Review of Respiratory Disease, 1987;135(3):747-760.

Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation, 1978;58(6): 1204-1211.

Birnie DH, Nery PB, Ha AC, et al. (2016). Cardiac sarcoidosis. Journal of the American College of Cardiology, 2016;68(4): 411-421.

Yazaki Y, Isobe M, Hiroe M, et al Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. The American journal of cardiology, 2001;88(9), 1006-1010.

Markatis E, Afthinos A, Antonakis E, et al. Cardiac sarcoidosis: diagnosis and management. Reviews in Cardiovascular Medicine.2020; 21(3): 321-338.

Bargagli E, Prasse A. Sarcoidosis: a review for the internist. Internal and emergency medicine. 2018;13: 325-331

From AM, Maleszewski JJ, Rihal CS. Current status of endomyocardial biopsy. In Mayo Clinic Proceedings. Elsevier. 2011;Vol. 86, No. 11, pp. 1095-1102.

Uemura A, Morimoto SI, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. American heart journal.1999;138(2): 299-302.

Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart rhythm.2014; 11(7): 1304-1323.

Crouser ED, Maier LA, Wilson KC, et al.(2020). Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. American journal of respiratory and critical care medicine. 2020;201(8): e26-e51.

Du Bois RM. Corticosteroids in sarcoidosis: friend or foe?. European Respiratory Journal. 1994;7(7): 1203-1209.

Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. The American journal of cardiology. 2001;88(9): 1006-1010.

Roberts WC, McAllister Jr HA, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). The American journal of medicine. 1977;63(1): 86-108.

Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978. Dec;58(6):1204-11

Takada K, Ina Y, Yamamoto M, et al. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy. Sarcoidosis. 1994;11(2):113-117.

Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 2019;74(7): e51-e156.

Nordkamp, LRO, Postema PG, Knops RE, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm,2016;13(2): 443-454

Kron J, Sauer W, Schuller J, et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace. 2013; 15:347–354.

Betensky BP, Tschabrunn CM, Zado ES, et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm.2012; 9:884–891.

Naruse Y, Sekiguchi Y, Nogami A, et al. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis. Circulation: Arrhythmia and Electrophysiology, 2014;7(3): 407-413.

Thomas P D, Hunninghake G.W. Current concepts of the pathogenesis of sarcoidosis. American Review of Respiratory Disease, 1987;135(3):747-760.

Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation, 1978;58(6): 1204-1211.

Birnie DH, Nery PB, Ha AC, et al. (2016). Cardiac sarcoidosis. Journal of the American College of Cardiology, 2016;68(4): 411-421.

Yazaki Y, Isobe M, Hiroe M, et al Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. The American journal of cardiology, 2001;88(9), 1006-1010.

Markatis E, Afthinos A, Antonakis E, et al. Cardiac sarcoidosis: diagnosis and management. Reviews in Cardiovascular Medicine.2020; 21(3): 321-338.

Bargagli E, Prasse A. Sarcoidosis: a review for the internist. Internal and emergency medicine. 2018;13: 325-331

From AM, Maleszewski JJ, Rihal CS. Current status of endomyocardial biopsy. In Mayo Clinic Proceedings. Elsevier. 2011;Vol. 86, No. 11, pp. 1095-1102.

Uemura A, Morimoto SI, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. American heart journal.1999;138(2): 299-302.

Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart rhythm.2014; 11(7): 1304-1323.

Crouser ED, Maier LA, Wilson KC, et al.(2020). Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. American journal of respiratory and critical care medicine. 2020;201(8): e26-e51.

Du Bois RM. Corticosteroids in sarcoidosis: friend or foe?. European Respiratory Journal. 1994;7(7): 1203-1209.

Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. The American journal of cardiology. 2001;88(9): 1006-1010.

Roberts WC, McAllister Jr HA, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). The American journal of medicine. 1977;63(1): 86-108.

Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978. Dec;58(6):1204-11

Takada K, Ina Y, Yamamoto M, et al. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy. Sarcoidosis. 1994;11(2):113-117.

Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 2019;74(7): e51-e156.

Nordkamp, LRO, Postema PG, Knops RE, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm,2016;13(2): 443-454

Kron J, Sauer W, Schuller J, et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace. 2013; 15:347–354.

Betensky BP, Tschabrunn CM, Zado ES, et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm.2012; 9:884–891.